+ Filter
Loading...
Custom Services order now ship next day

Anti-SSTR Recombinant Antibody Products

Loading...

Anti-SSTR Products

More Infomation

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs is pleased to introduce our comprehensive portfolio of anti-SSTR recombinant antibody products, meticulously developed to support and enhance the endeavors of researchers and pharmaceutical entities globally. Leveraging unparalleled scientific expertise and state-of-the-art technological platforms, these antibodies exhibit exceptional specificity and high affinity, thereby facilitating accelerated progress in critical investigations across diverse therapeutic and diagnostic domains worldwide. We invite you to explore how these innovative solutions can significantly augment your research initiatives.

SSTR: A Pivotal Target for Neuroendocrine Tumors

Somatostatin receptors (SSTRs) are a group of five G protein-coupled receptor subtypes (SSTR1-5) that control the various activities of somatostatin, a regulatory peptide hormone. These receptors are widely distributed throughout the body, influencing critical physiological processes such as hormone secretion, cell proliferation, neurotransmission, and immune modulation. Extensive research has highlighted their significant involvement in various pathological conditions, including neuroendocrine tumors, other cancers, inflammatory disorders, and metabolic diseases, making them crucial targets for novel therapeutic and diagnostic strategies.

Alternative Names

Somatostatin receptor; SSTR; SSTR1; SSTR2; SSTR3; SSTR4; SSTR5.

Background

The antibodies that specifically bind to the extracellular loop 2 (ecl2) of human somatostatin receptor (hSSTR) are used for diagnosing and treating various indications, including cancer and carcinoid syndrome.

Anti-SSTR rAb Products

Creative Biolabs' anti-SSTR recombinant antibody products are engineered with precision to provide exceptional performance. These antibodies boast high specificity and affinity for their respective SSTR subtypes, ensuring accurate detection and manipulation. Produced using advanced recombinant technology, they offer unparalleled batch-to-batch consistency and purity, minimizing experimental variability and accelerating your research breakthroughs in SSTR-related studies, from basic science to drug discovery.

Table 1. Featured anti-SSTR recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
AFC-562CL Afuco™ Anti-Human SSTR ADCC Recombinant Antibody, ADCC Enhanced Human Human ADCC Enhanced Antibody
TAB-584CL Anti-Human SSTR Recombinant Antibody Human Human Antibody

Creative Quality Control

At Creative Biolabs, every anti-SSTR recombinant antibody undergoes a stringent, multi-faceted quality control process. Our comprehensive testing includes ELISA, Western Blot, and flow cytometry to verify specificity and sensitivity. We also perform rigorous purity analysis and binding assays to ensure optimal performance and reproducibility, guaranteeing that our clients receive only the highest-grade reagents for their critical experiments.

Customer Reviews

Excellent
Mi***l
Anti-Human SSTR Recombinant Antibody (TAB-584CL)
The anti-SSTR1 recombinant antibody from Creative Biolabs has been a game-changer for our neuroendocrine tumor research. Its exceptional specificity and low background noise significantly improved our IHC staining results, allowing us to confidently identify SSTR1 expression in patient samples. The consistency across batches is truly impressive, saving us valuable time and resources in our lab.
20/Oct/2023
Excellent
Lo***y
Afuco™ Anti-Human SSTR ADCC Recombinant Antibody, ADCC Enhanced (AFC-562CL)
We've incorporated Creative Biolabs' anti-SSTR2 recombinant antibodies into our drug screening pipeline, and the results have been outstanding. The high affinity and reliable performance of these antibodies have enabled us to develop highly sensitive assays for ligand binding and receptor activation. Their products have become an indispensable tool for accelerating our therapeutic development efforts.
11/Jun/2024
Excellent
Je***j
Anti-Human SSTR Recombinant Antibody (TAB-584CL)
For our SSTR-targeted imaging studies, the anti-SSTR5 recombinant antibody from Creative Biolabs delivered superior performance. The antibody's robust binding characteristics and excellent signal-to-noise ratio provided clear and precise imaging data, which was crucial for validating our novel imaging agents.
10/Mar/2025

rAb Production

Our anti-SSTR recombinant antibody products are manufactured in-house using cutting-edge expression systems and purification techniques. This controlled environment ensures consistent quality and scalability. We utilize advanced bioreactor technology and optimized protocols to produce high yields of highly active and pure antibodies, meeting the diverse demands of both academic research and industrial applications with efficiency.

Featured Anti-SSTR Recombinant Antibody Production PlatformsFig.1 Milligram-scale. (Creative Biolabs Original)
Fig.1 Milligram-scale anti-SSTR recombinant antibody production.

Fig.2 Gram-scale. (Creative Biolabs Original)Fig.2 Gram-scale anti-SSTR recombinant antibody production.

rAb Modalities

Our anti-SSTR recombinant antibody products are available in multiple modalities, offering versatile options for various experimental setups.

Fig.3 SSTR antibody production and modalities. (Creative Biolabs Original)Fig.3 Full-length anti-SSTR recombinant antibody production and modalities.

SSTR-Targeted Drug Information

Table 2. Public drug targeting SSTR.

Company Research phase Classification Condition
Curium
RadioMedix
Rigshospitalet (Originator)
University of Copenhagen (Originator)
Launched - 2020 Copper Complexes
Macrocyclic Peptides
Nuclear Imaging Agents
Octreotides
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radiopharmaceuticals
Somatostatin Analogues
Neuroendocrine cancer
Advanced Accelerator Applications
Advanced Accelerator Applications (AAA) (Advanced Accelerator Applications)
Göteborg University (Goeteborgs Universitet)
IASON
ITM Isotopen Technologien (ITM Isotope Technologies Munich)
ITM Isotope Technologies Munich
Jiangsu Hengrui
Society Nuclear Medicine Mol Imaging
Society of Nuclear Medicine Molec Im (Society Nuclear Medicine Mol Imaging)
Universitaetsspitals Basel
University of Iowa
Launched - 2017 Gallium Complexes
Macrocyclic Peptides
Nuclear Imaging Agents
Octreotides
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radiopharmaceuticals
Somatostatin Analogues
Cancer
Cancer, gastroenteropancreatic (neuroendocrine)
Cancer, pituitary
Neuroendocrine cancer
Advanced Accelerator Applications
Advanced Accelerator Applications (AAA) (Advanced Accelerator Applications)
BioSynthema (Advanced Accelerator Applications)
CanProbe
FUJIFILM RI Pharma (FUJIFILM Toyama Chemical)
FUJIFILM Toyama Chemical
Medtronic (Originator)
POINT Biopharma
Launched - 2017 Lutetium Complexes
Macrocyclic Peptides
Octreotides
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radionuclide Therapy
Radiopharmaceuticals
Somatostatin Analogues
Cancer, breast
Cancer, gastroenteropancreatic (neuroendocrine)
Cancer, intestinal (neuroendocrine)
Cancer, lung (small cell) (SCLC) (extensive)
Cancer, pancreas (neuroendocrine)
Glioblastoma
Melanoma
Meningioma
Neuroendocrine cancer
Advanced Accelerator Applications
Advanced Accelerator Applications (AAA) (Advanced Accelerator Applications)
E Kennedy Shriver NI Child Health Human
National Cancer Institute
RadioMedix
Launched - 2016 Gallium Complexes
Macrocyclic Peptides
Nuclear Imaging Agents
Octreotides
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radiopharmaceuticals
Cancer, gastroenteropancreatic (neuroendocrine)
Cancer, liver (hepatocellular carcinoma)
Cancer, prostate (castration-resistant), metastatic
Cushing syndrome
Neuroendocrine cancer
Neurologic cancer
Osteomalacia, oncogenic
Amersham (GE Healthcare)
Bayer (Originator)
Berlex (Bayer)
Cardinal Health
CIS Bio International (Ion Beam Applications (IBA))
Diatide (Bayer)
GE Healthcare
Ion Beam Applications (IBA)
Launched - 1999 Macrocyclic Peptides
Nuclear Imaging Agents
Peptide-Drug Conjugates
Polypeptides, from 10 AA to 40 AA
Radiopharmaceuticals
Technetium Complexes
Cancer
Cancer, lung
FUJIFILM RI Pharma (FUJIFILM Toyama Chemical)
FUJIFILM Toyama Chemical
Louisiana State University
Mallinckrodt (Originator)
Novartis (Originator)
RadioMedix
Takeda
Tyco Healthcare Japan (Medtronic)
Launched - 1994 Indium Complexes
Macrocyclic Peptides
Nuclear Imaging Agents
Octreotides
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radionuclide Therapy
Radiopharmaceuticals
Somatostatin Analogues
Cancer
Diagnostics
Neuroendocrine cancer
Sarcoidosis
Universita di Bologna Launched Gallium Complexes
Macrocyclic Peptides
Nuclear Imaging Agents
Octreotides
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radiopharmaceuticals
Cancer
Barts and the London NHS (Originator)
Leopold-Franzens Universitaet Innsbruck (Originator)
National Centre Nuclear Research Poland
Launched Macrocyclic Peptides
Nuclear Imaging Agents
Octreotides
Peptide-Drug Conjugates
Polypeptides, from 10 AA to 40 AA
Radiopharmaceuticals
Technetium Complexes
Neuroendocrine cancer
All India Institute of Medical Sciences (Originator)
RayzeBio
Phase III Actinium Complexes
Macrocyclic Peptides
Octreotides
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radionuclide Therapy
Radiopharmaceuticals
Somatostatin Analogues
Cancer, gastroenteropancreatic (neuroendocrine)
Cancer, lung (small cell) (SCLC) (extensive)
Multiple myeloma
DuChemBio
ITG Isotope Technologies Garching (ITM Isotope Technologies Munich)
ITM Isotopen Technologien (ITM Isotope Technologies Munich)
ITM Isotope Technologies Munich
RadioMedix
Universitaetsspitals Basel (Originator)
Phase III Lutetium Complexes
Macrocyclic Peptides
Octreotides
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radionuclide Therapy
Radiopharmaceuticals
Somatostatin Analogues
Cancer, gastroenteropancreatic (neuroendocrine)
Cancer, solid tumor
Neuroendocrine cancer
Bayer (Originator)
Ipsen
Phase III Macrocyclic Peptides
Nuclear Imaging Agents
Oligopeptides, less than 10 AA
Peptide-Drug Conjugates
Radiopharmaceuticals
Technetium Complexes
Diagnostics

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

At Creative Biolabs, we are dedicated to providing superior anti-SSTR recombinant antibody products that propel scientific discovery forward. Our dedication to quality and innovation guarantees that you have the greatest research tools available. Explore our complete catalogue and get in touch with us right now to discuss your individual project requirements and learn how our experience may help you achieve your next breakthrough.

Go to compare

Go to compare